Перейти к основному содержанию
AkademIndex

Продукты

Для разработчиков

AkademBaseОткрытый API экосистемы
← Назад к работе

Работы, на которые ссылается эта работа

Работ: 98

Работа: Natural killer cells, macrophages and dendritic cells as innate immune therapies for blood cancers

  1. Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors

    Enli Liu, David Marín, Pinaki P. Banerjee +24

    Статья2020Цитирований: 6
    ABI
  2. Tumor-Associated Macrophages: From Mechanisms to Therapy

    Roy Noy, Jeffrey W. Pollard

    Обзорная статья2014Цитирований: 5
    ABI
  3. CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors

    Lei Peng, Giacomo Sferruzza, Luojia Yang +2

    Обзорная статья2024Цитирований: 5
    ABI
  4. The clinical landscape of CAR NK cells

    Lasse Vedel Jørgensen, Emil Birch Christensen, Mike Bogetofte Barnkob +1

    Обзорная статья2025Цитирований: 5
    ABI
  5. The Molecular Mechanism of Natural Killer Cells Function and Its Importance in Cancer Immunotherapy

    Sourav Paul, Girdhari Lal

    Обзорная статья2017Цитирований: 3
    ABI
  6. Dendritic cell subsets in cancer immunity and tumor antigen sensing

    Annalisa Del Prete, Valentina Salvi, Alessandra Soriani +4

    Обзорная статья2023Цитирований: 3
    ABI
  7. The interplay between innate and adaptive immunity in cancer shapes the productivity of cancer immunosurveillance

    Renee B. Chang, Gregory L. Beatty

    Обзорная статья2020Цитирований: 3
    ABI
  8. Macrophages in immunoregulation and therapeutics

    Shanze Chen, Abdullah F. U. H. Saeed, Quan Liu +5

    Обзорная статья2023Цитирований: 2
    ABI
  9. Understanding the tumor microenvironment for effective immunotherapy

    Habib Sadeghi Rad, James Monkman, Majid Ebrahimi Warkiani +4

    Обзорная статья2020Цитирований: 2
    ABI
  10. Reactive Oxygen Species and Antitumor Immunity—From Surveillance to Evasion

    Andromachi Kotsafti, Marco Scarpa, Ignazio Castagliuolo +1

    Обзорная статья2020Цитирований: 2
    ABI
  11. Inflammation and tumor progression: signaling pathways and targeted intervention

    Huakan Zhao, Lei Wu, Guifang Yan +4

    Статья2021Цитирований: 2
    ABI
  12. Natural killer cell homing and trafficking in tissues and tumors: from biology to application

    Guanghe Ran, Yu qing Lin, Lei Tian +4

    Обзорная статья2022Цитирований: 2
    ABI
  13. Emerging roles of CAR-NK cell therapies in tumor immunotherapy: current status and future directions

    Yan Zhong, Jingfeng Liu

    Статья2024Цитирований: 2
    ABI
  14. The role of tumor-associated macrophages (TAMs) in tumor progression and relevant advance in targeted therapy

    Qiyao Yang, Ningning Guo, Yi Zhou +3

    Обзорная статья2020Цитирований: 2
    ABI
  15. NK Cells Armed with Chimeric Antigen Receptors (CAR): Roadblocks to Successful Development

    Ali Bashiri Dezfouli, Mina Yazdi, A. Graham Pockley +4

    Обзорная статья2021Цитирований: 2
    ABI
  16. Dendritic Cell Vaccines: A Shift from Conventional Approach to New Generations

    Kyu-Won Lee, Judy Wai Ping Yam, Xiaowen Mao

    Обзорная статья2023Цитирований: 2
    ABI
  17. Exploring the potential of CAR-macrophage therapy

    Yongyu Shi, Xia Li, Yan Dong +3

    Обзорная статья2024Цитирований: 2
    ABI
  18. Paradoxical effects of chemotherapy on tumor relapse and metastasis promotion

    Crescenzo D’Alterio, Stefania Scala, Gabriella Sozzi +2

    Обзорная статья2019Цитирований: 2
    ABI
  19. Shaping Polarization Of Tumor-Associated Macrophages In Cancer Immunotherapy

    Jing Gao, Yuanzheng Liang, Liang Wang

    Обзорная статья2022Цитирований: 2
    ABI
  20. Cancer-Associated Fibroblasts and Tumor-Associated Macrophages in Cancer and Cancer Immunotherapy

    Hans Raskov, Adile Orhan, Shruti Gaggar +1

    Обзорная статья2021Цитирований: 2
    ABI
  21. The role of dendritic cells in cancer and anti-tumor immunity

    Ariel E. Marciscano, Niroshana Anandasabapathy

    Обзорная статья2021Цитирований: 2
    ABI
  22. Novel strategies to overcome tumor immunotherapy resistance using CAR NK cells

    Junhui Guo, Ali Afzal, Sadia Ahmad +7

    Обзорная статья2025Цитирований: 2
    ABI
  23. NK Cells in the Treatment of Hematological Malignancies

    Ana Pilar González, Mónica Villa-Álvarez, Christian Sordo‐Bahamonde +2

    Обзорная статья2019Цитирований: 2
    ABI